Core Viewpoint - Tianyi Medical (301097) experienced a decline in stock price, closing at 51.89 yuan on December 25, 2025, down 5.43% with a turnover rate of 6.49% and a trading volume of 18,800 hands, resulting in a transaction amount of 98.79 million yuan [1] Group 1: Financial Performance - For the first three quarters of 2025, Tianyi Medical reported a main revenue of 387 million yuan, an increase of 24.14% year-on-year [3] - The net profit attributable to shareholders reached 20.09 million yuan, up 216.81% year-on-year, while the net profit after deducting non-recurring gains and losses was 8.41 million yuan, soaring 762.11% year-on-year [3] - In Q3 2025, the company achieved a quarterly main revenue of 160 million yuan, a year-on-year increase of 48.03%, with a quarterly net profit of 10.61 million yuan, up 227.86% year-on-year [3] Group 2: Financing and Capital Flow - On December 25, 2025, Tianyi Medical had a net inflow of retail investor funds amounting to 4.88 million yuan, which accounted for 4.93% of the total transaction amount [1] - The financing data indicated a financing buy of 4.75 million yuan and a financing repayment of 4.31 million yuan, resulting in a net financing buy of 0.43 million yuan [2] - The total balance of financing and securities lending stood at 51.97 million yuan [2]
天益医疗（301097）12月25日主力资金净卖出680.83万元